title: Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study.
abstract: Mutations in the thymidine kinase (TK) gene of herpes simplex virus (HSV) may confer resistance to acyclovir (ACV). Because of the high genetic polymorphism of this gene, discriminating between mutations related to resistance and mutations related to gene polymorphism can be difficult, especially when no sensitive strain has been previously isolated from the same patient. To assess the role of the mutations located at codons 51, 77, 83, and 175, previously detected in HSV-1 clinical isolates (F. Morfin, G. Souillet, K. Bilger, T. Ooka, M. Aymard, and D. Thouvenot, J. Infect. Dis. 182:290-293, 2000), in the acquisition of resistance to ACV, four mutants with site-directed mutations at these respective codons were constructed. The enzymatic activity of the proteins, produced using both a reticulocyte lysate system and a bacterial system, was evaluated using [(3)H]thymidine as substrate. This site-directed mutagenesis revealed that mutations at codons 51, 83, and 175 induce a loss of HSV-1 TK activity and are thus clearly involved in the acquisition of resistance to ACV. On the other hand, the mutation at codon 77 does not affect enzyme activity.
authors.affiliation: Laboratoire de Virologie, Hospices Civils de Lyon, Domaine Rockefeller, 8 avenue Rockefeller, 69373 Lyon cedex 08, France. e.frobert@wanadoo.fr
authors.forename: E
authors.initials: E
authors.lastname: Frobert
authors.forename: T
authors.initials: T
authors.lastname: Ooka
authors.forename: J C
authors.initials: JC
authors.lastname: Cortay
authors.forename: B
authors.initials: B
authors.lastname: Lina
authors.forename: D
authors.initials: D
authors.lastname: Thouvenot
authors.forename: F
authors.initials: F
authors.lastname: Morfin
mesh_terms: D000212:Acyclovir / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D018139:Simplexvirus / Q000187:drug effects* / Q000201:enzymology*; D013937:Thymidine Kinase / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D000998:Antiviral Agents; D013937:Thymidine Kinase; D000212:Acyclovir
references.citation: J Infect Dis. 1999 Aug;180(2):487-90
references.pmid: 10395866
references.citation: J Gen Virol. 1998 Sep;79 ( Pt 9):2083-92
references.pmid: 9747715
references.citation: J Clin Microbiol. 2000 May;38(5):1839-44
references.pmid: 10790110
references.citation: J Infect Dis. 2000 Jun;181(6):2055-8
references.pmid: 10837192
references.citation: J Infect Dis. 2000 Jul;182(1):290-3
references.pmid: 10882609
references.citation: Exp Eye Res. 2000 Oct;71(4):353-9
references.pmid: 10995556
references.citation: J Virol. 2001 Apr;75(7):3105-10
references.pmid: 11238837
references.citation: Drug Resist Updat. 2002 Apr;5(2):88-114
references.pmid: 12135584
references.citation: J Clin Microbiol. 2004 Jan;42(1):242-9
references.pmid: 14715760
references.citation: J Gen Virol. 1983 Mar;64 Pt 3:523-32
references.pmid: 6298344
references.citation: Proc Natl Acad Sci U S A. 1985 Feb;82(4):1074-8
references.pmid: 3156376
references.citation: J Gen Virol. 1986 Apr;67 ( Pt 4):753-8
references.pmid: 3007662
references.citation: J Gen Virol. 1989 Apr;70 ( Pt 4):869-79
references.pmid: 2543763
references.citation: Ann Intern Med. 1990 Mar 15;112(6):416-22
references.pmid: 2155570
references.citation: J Gen Virol. 1990 Dec;71 ( Pt 12):2979-87
references.pmid: 2273392
references.citation: J Virol. 1997 May;71(5):3872-8
references.pmid: 9094663
references.citation: Electrophoresis. 1997 May;18(5):819-25
references.pmid: 9194614
references.citation: Antimicrob Agents Chemother. 1998 Apr;42(4):868-72
references.pmid: 9559798
references.citation: J Infect Dis. 1998 Aug;178(2):297-303
references.pmid: 9697707
references.citation: J Med Virol. 1998 Oct;56(2):151-8
references.pmid: 9746072
references.citation: Antimicrob Agents Chemother. 1999 Oct;43(10):2412-6
references.pmid: 10508017